Rudi
@rudiwerner2017
Followers
34
Following
111
Media
0
Statuses
79
Joined February 2017
Check out our newest publication on #PSMA #PET with a novel radiotracer. https://t.co/JfLdnp3o1r Written by the incomparable @SaraSheikhbahai. @rudiwerner2017 @liljasolnes @michael_gorin
pubmed.ncbi.nlm.nih.gov
[18F]F-Florastamin is a promising new radioligand for PSMA-targeted PET with suitable lesion detectability and high TBR at both time points.
0
1
3
Excellent work by Dr. Kevin Leung. https://t.co/O1jF0R8kwa Working towards lesion-level characterization of findings on #PSMA #PET #RADS @michael_gorin @pienta_brady
0
2
3
#AI for #breastcancer lesion detection. Jeff Leal is one of the smartest guys I know and he did a phenomenal job on this project. @liljasolnes
pubmed.ncbi.nlm.nih.gov
This pilot work has demonstrated the ability of AI-based workflow using DL-CNNs to specifically identify breast cancer tissue as determined by [18F]FDG avidity in a PET/CT study. The high sensitivity...
0
5
9
CXCR4 for targeted imaging…now on to CXCR4 targeted therapy? https://t.co/vAmZk7e83P
#MedicalImaging #PETScan #Cancer
0
16
32
Looking for more information on 18F-labeled #PSMA #PET radio tracers? Check out our latest review. https://t.co/bj6omRzvrD
#molecularimaging @liljasolnes @rudiwerner2017 @michael_gorin
pubmed.ncbi.nlm.nih.gov
Much of the modern growth in nuclear medicine has been driven by PET imaging of prostate-specific membrane antigen (PSMA) in men with prostate cancer. Fluorine-18 is the ideal PET radionuclide with a...
0
5
13
Phantom studies for scanner calibration are essential prior to in-vivo examinations: https://t.co/OBRDlJK8bh Now everything set-up to perform inflammatory-targeted scans within @sfb1525!
0
0
1
How effective and safe is prolonged ¹⁷⁷Lu-PSMA treatment? https://t.co/LiCpVoTPpm
#PrecisionOncology #NuclearMedicine #ProstateCancer
0
18
32
Targeting CXCR4: Another promising theranostic approach. https://t.co/NcUjHIhx3J
#PersonalizedMedicine #NuclearMedicine #Lymphoma
0
21
41
Had the privilege to share the stage with @rudiwerner2017 and @liljasolnes today at #AACR to discuss radioligand therapy for various cancers. Some technical glitches, but it was a well-attended and highly educational session. #RLT is here as a pillar of modern cancer therapy.
0
1
5
Nice publication from @rudiwerner2017 and team. CXCR4 imaging agents are promising for multiple myeloma and other cancers. #molecularimaging
pubmed.ncbi.nlm.nih.gov
In patients with solid tumors imaged with [68Ga]Ga-PentixaFor PET/CT, no relevant tumor sink effect was noted. This observation may be of relevance for therapies with radioactive and non-radioactive...
0
3
8
@M_Sadaghiani @liljasolnes As usual, great work from Moe Sadaghiani. Even when he is gearing up for the core exam, he is still productive!
Check out the latest publication from our group on the effectiveness of PSMA endorediotherapy! @HopkinsNucs
https://t.co/DQsdYkmuQU
0
1
4
What can reporting and data systems (RADS) do for you? Quite a bit, if clinically useful and validated. Check out latest from @rudiwerner2017 and his team. https://t.co/f9j0XQn5ln
#RADS #molecularimaging
pubmed.ncbi.nlm.nih.gov
A framework-focused reader training can reduce anxiety to report on SSTR-PET/CTs, in particular for inexperienced readers. This may allow for a more widespread adoption of this system, e.g., in...
0
1
1
https://t.co/YgFSgCKt1D Proud of the team behind this. Rare imaging trial in which we found important clinical information and made a fundamental discovery. #PCF funded. #PSMA @PCF_Science @rudiwerner2017 @michael_gorin @AliSalavatiMD @HopkinsMedNews
0
5
7
Exited to share our recent collaborative review in @EUplatinum on advanced imaging methods for renal mass characterization! Heavy lifting by @Eduardrssl with amazing coauthors: @HopkinsNucs @uretericbud @ivpedrosa @u_capitanio & Prof. Oosterwijk https://t.co/LnaH6TLFuz
0
1
0
An overview of imaging #prostatecancer with #pylarify #PSMA. Watch this space for future efforts. @rudiwerner2017 @michael_gorin
pubmed.ncbi.nlm.nih.gov
Prostate-specific membrane antigen (PSMA)-directed positron emission tomography (PET) has gained increasing interest for imaging of men affected by prostate cancer (PC). In recent years, 68Ga-labeled...
0
1
5
Need something long to read? Review on molecular imaging in oncology from @HopkinsNucs and @radnucmp. Lesson: journals need to give us word count limits. #molecularimaging #PSMA @rudiwerner2017 @ASCO @AliSalavatiMD @liljasolnes
pubmed.ncbi.nlm.nih.gov
The authors define molecular imaging, according to the Society of Nuclear Medicine and Molecular Imaging, as the visualization, characterization, and measurement of biological processes at the...
0
10
23
Tonight we are joined by @SaraSheikhbahai, @liljasolnes, as well as our #AJRChat moderators @drcyncity & @CBoonie_nanoIR. Who else is joining us?
0
3
6
We are proud to introduce Dr. Sanjay Jain, Dr. @AlvaroAOrdonez and Dr. @FilipaM05 of @SanjayJain_Lab & @HopkinsMedicine. This team is a finalist in the #IDeaIncubator2021 competition, happening LIVE tonight during #IDWeek2021 festivities! Register now: https://t.co/KWwSIS5aTB
1
5
10
Excellent 11min talk: #ProstateCancer Initial Staging and Evaluation of Recurrent Disease with PSMA-Targeted PET by @Hopkins_Rad @HopkinsNucs colleague Dr. Steven Rowe: https://t.co/fWOdBAjJQ8 e.g. change in #RT plan on the basis of #PSMA #PET scan findings.
0
13
27